Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2011-11-22
Sims, Jason (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S039000
Reexamination Certificate
active
08063059
ABSTRACT:
The invention relates to the use of a composition comprising kappa opioid receptor antagonists for producing a drug for the treatment of dissociative disorders in humans.
REFERENCES:
patent: 5028612 (1991-07-01), Glover
patent: 5780479 (1998-07-01), Kim
patent: 6242456 (2001-06-01), Shuster et al.
patent: 2002/0045572 (2002-04-01), Clemens
patent: 2002/0091075 (2002-07-01), Carlezon, Jr.
patent: 2007/0231269 (2007-10-01), Birch et al.
patent: 0451009 (1991-09-01), None
patent: 0213759 (2002-02-01), None
patent: 0249643 (2002-06-01), None
patent: 03080022 (2003-10-01), None
patent: 2005084654 (2005-09-01), None
patent: 2005117838 (2005-12-01), None
Simeon, Daphne, “Depersonalisation Disorder; A Contempory Overview”, CNS Drugs, Adis Data International, Auckland, NZ, vol. 18 No. 6, 2004, pp. 343-354, XP009085195.
Mague, Stephen D. et al., Antidepressant-Like Effects of k-Opioid Receptor Antagonisgts in the Forced Swim Test in Rats, Journal of Pharmacology and Experimental Therapeutics, vol. 365 No. 1, Apr. 1, 2003, pp. 323-330, XP002437983.
Vadivelu, Nalini et al., “Buprenorphine Pharmacology and Clinical Applications”, Seminars in Anethesia, Saunders, CO, New York, NY, vol. 23, No. 4, Dec. 2004, pp. 281-290, XP004727515.
Maremmani, I. et al., “Buprenorphine As a Psychoactive Drug”, Italian Journal of Psychopathology, 2006, Italy, vol. 12, No. 3, 2006, pp. 332-341, XP002437984.
Metcalf, Mathew D et al., “Kappa Opioid Antagonists: Past Successes and Future Prospects”, AAPS Journal 2005, vol. 7, No. 3, pp. E704-E722, XP002437985.
Emodys GmbH
Patent Central LLC
Pendorf Stephan A.
Sims Jason
Vakili Zohreh
LandOfFree
Use of compositions containing kappa-opioid receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of compositions containing kappa-opioid receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of compositions containing kappa-opioid receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4285940